Your physician will help you decide
CagriSema as add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre phase 3 study
It is important to note that the specific Klow combination itself has not been systematically evaluated in clinical studies, and any observed effects in research models should not be interpreted as evidence of safety or efficacy in humans or animals
PlexusDx offers the Precision Peptide Genetic Test, $298, that maps your genetic predispositions across 14 metabolic pathways and 49 peptides, including key variants in GIPR and FTO, and MC4R genes
However, since our analysis showed improved all-cause mortality outcomes in our target population, we hope GLP-1 use can be considered in a patients treatment plan to improve outcomes. Study findings suggest the initiation of additional prospective, randomized studies to validate and extrapolate results